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A MODEL OF THE ECONOMIC IMPACT OF AFRICAN 
HORSE SICKNESS TO THE EQUINE BREEDING INDUSTRY 




A deterministic model for the economic impact of African Horse Sickness (AHS) on the 
equine breeding industry was developed for South Africa. It was applied to the case of 
the 2007/2008 outbreak of AHS in the Eastern Cape as a pilot application of the model, 
using data from breeders in the province. It was concluded that the deterministic model’s 
extension to include other areas of equine livelihoods could be effective in exposing the 
need for further research into the control and treatment of AHS in South Africa.  
1.  INTRODUCTION 
UNLIKE THE SPHERE OF HUMAN HEALTH, in which the objective is to eliminate 
loss and suffering, the objective of animal health is in fact to eliminate economic loss 
(Perry et al., 2001: 236). Viral diseases pose a significant threat to the equine industry all 
over the world due to the large scale and high rate of movement of horses for breeding 
and competition purposes both within and between countries (MacLachlan et al., 2007: 
5578). African horse sickness (AHS) is no exception. AHS is a non-contagious, infectious 
disease caused by the African Horse Sickness Virus which is transmitted by the biting  
midge,  Culicoides  imicola,  and  has  a  mortality rate  of over  90%  for  AHS  naive horses 
(MacLachlan and Guthrie, 2010: 40; Mellor and Hamblin, 2004: 446). It affects equids in 
most of sub-Saharan Africa, which is considered its endemic area, but epizootics have 
also occurred in North Africa (spread via the movement of nomads with their animals) 
Europe and the Middle and Near East (MacLachlan and Guthrie, 2010: 41; Niven, 2005; 
Mellor and Hamblin, 2004: 450). In 1959, there was an outbreak of the disease in Iran, 
spreading from there to the Persian Gulf, India, Pakistan, Turkey and Afghanistan in the 
following two years, and killing in the region of 300 000 horses over the period of the 
outbreak (Niven, 2005). Between 1987 and 1990, AHS spread to Spain via zebra that 
were  imported  from  Namibia  (MacLachlan  and  Guthrie,  2010:  41).  In  1997,  in 
recognition of its devastating socio-economic effects and significance in the international 
trade of equids, the World Organisation for Animal Health (OIE) classified AHS as a List 
A  notifiable  disease  (von  Teichman  and  Smit,  2008:  5014).  MacLachlan  and  Guthrie 
(2010: 41) warn that the spread of AHS to North Africa could quickly lead to its dispersal 
across the Mediterranean basin and into Europe or the Middle East, as was seen with the 
Bluetongue virus which is transmitted by the same vector. Were this to happen with the 2 
 
AHS  virus,  the  economic  effects  would  be  catastrophic  as  these  regions  are  highly 
involved in the international trade and movement of horses (MacLachlan and Smit, 2010: 
41). 
Since the 19th century, AHS has established itself as endemic almost completely across 
South Africa and cases have been observed virtually countrywide with seasonal outbreaks 
disrupting the equine industry on a regular basis (Niven, 2005; Mellor and Hamblin, 2004: 
450). Furthermore, South Africa is the only country in which all nine serotypes of the 
virus have been isolated (von Teichman and Smit, 2008: 5014). Because the reproduction 
of Culicoides is reliant on wet, humid conditions, the occurrence of dry summers does 
result in the reduced prevalence of AHS in South Africa in some years. Given favourable 
conditions, the disease will begin to emerge in the summer rainfall areas in February and 
through to April, subsiding at the first signs of frost, but some cases have been observed 
in May and June in the Lowveld areas (Niven, 2005).  
The Onderstepoort Veterinary Institute in Pretoria has developed a vaccine to cover 
seven of the nine serotypes, and it is compulsory that the two separate injections are 
administered to all horses in South Africa on a regular basis, except those within the free 
and surveillance zones in the Western Cape (von Teichman and Smit, 2008: 514-515). 
The vaccine, produced by Onderstepoort Biological Products Ltd., is an attenuated live 
virus vaccine which has been widely used throughout southern Africa since 1991 (von 
Teichman and Smit, 2008: 5014). The vaccine has been shown to build up a level of 
immunity in horses that are regularly vaccinated, however, they are never fully protected 
from the  disease,  and  infection  can  still  occur  in regularly  vaccinated  horses  (Niven, 
2005). Furthermore, it has been suggested that vaccinating adult horses too often can 
reduce their immunity to the disease (Niven, 2005). But it is clear that the introduction 
and widespread use of the vaccine by horse owners in South Africa has been successful in 
significantly reducing the number of deaths caused by the disease. There is, unfortunately, 
no known cure for the disease, though there are several treatments that have been seen to 
have positive effects, but with mixed successes.  
Some recent outbreaks of AHS were reported in KwaZulu Natal, the Eastern Cape 
and Gauteng in 2003 and in the Western Cape in 2004 (von Teichman and Smit, 2008). 
In  2007,  433  cases  of  AHS  in  the  Eastern  Cape  were  reported  to  the  local  State 
Veterinary Office (African Horse Sickness Trust, 2010). Because these outbreaks and 
other isolated cases of the disease continue to occur across South Africa, the disease 
“impacts  significantly  on  the  local  economic  and  recreational  horse  industry”  (von 
Teichman  and  Smit,  2008:  5014),  and  it  is  thus  important  to  determine  just  how 
significant this economic impact is.  
The primary objective of this study is to develop a model that is a suitable tool for 
calculating the economic impact of AHS on the sport horse breeding industry in the 
South African context. In order to test the comprehensiveness of the model, the case of 
the 2007/2008 outbreak of AHS in the Eastern Cape will be applied as a pilot study. In 
addition, the loss-expenditure frontier will be considered as a complementary tool for 
analysis of control strategies for AHS in South Africa. 
2.  THEORETICAL APPROACH 
 
A deterministic economic model will be constructed using examples of models from case 
studies of livestock diseases from other countries and applying those methods to the case 3 
 
of African Horse Sickness in the equine breeding industry in South Africa (see Bennett et 
al.,  1999;  Mahul  and  Durand,  2000;  Mukhebi  et  al.,  1999).  It  will  be  modelled 
predominantly on the example of Velthuis et al. (2010), who conducted a comprehensive 
analysis of the financial losses incurred as a result of outbreaks of the Bluetongue virus in 
the Netherlands in 2006 and 2007 respectively using a deterministic economic model. 
The Culicoides imicola midge is also the vector of Bluetongue, which affects sheep, goats 
and cows (Niven, 2005, Velthuis et al., 2010: 294). The model developed in this study and 
the authors’ method of investigation provide a good benchmark for research into the 
economic impact of AHS in South Africa as the case involved very similar inputs and 
scenarios to those found for AHS in South Africa. Velthuis et al. (2010: 303) suggest that 
their  model  is  suitable  to  assist  authorities  and  stakeholders  at  the  sector  level  in 
retrospectively assessing the effectiveness of control measures taken during an outbreak 
and in planning future controls or vaccination strategies. A similar model in the case of 
AHS in South Africa will seek to determine the economic impact of the disease in the 
equine breeding industry in the province.  
The basic model produced by Velthuis et al. (2010: 295) is as follows: 
 
L = ∑i∑jPi.j + Ti.j +Di + Mi.j,              (1) 
 
where  L  represents  the  total  change  to  the  entire  livestock  population  due  to  the 
epizootic, P the production losses of farm type i in the context of animal type j, T the 
corresponding  treatment  costs,  D  the  diagnostic  costs,  and  M  the  cost  of  control 
measures. Each of these is then broken down further into equations involving  more 
specific inputs. Data was collected for each input from each farm type and for each 
animal  type  over  the  periods  of  the  two  epidemics  of  the  Bluetongue  virus  in  the 
Netherlands in 2006 and 2007 respectively, and entered into the model. This research 
method is a sound starting point for an investigation into the case of AHS in the breeding 
industry in South Africa, providing a good framework which will be adapted to create a 
model that can accommodate the inputs involved in the case in question.  
The model will then be applied to the case of the 2007/2008 outbreak of AHS in the 
Eastern Cape, and data will be obtained from a small number of breeders in the province 
in order to assess the functionality of the model. 
 
3.  A MODEL FOR AFRICAN HORSE SICKNESS IN SOUTH AFRICA 
 
Drawing from the model used by Velthuis et al. (2010) to quantify the financial costs of 
outbreaks of the Bluetongue virus, the following model was constructed for AHS in the 
equine breeding industry in South Africa: 
 
L = P + T + D + M                               (3) 
 
Where:  
P = production losses 
T = treatment costs 
D = diagnostic cost 
M = cost of control measures 
         4 
 
Production losses are calculated as the value of horses that were lost to AHS over the 
period, provided by the owner, including an estimation of their keeping expenses over 
their  lifetime  and  the  cost  to  the  owner  of  having  the  carcass  removed  from  their 
premises. Production losses also include the value of any foals that are lost to still births 
or abortions due to the infection of a pregnant mare. 
There is currently no cure for AHS, and treatment is limited to making the horse more 
comfortable and hoping for the best. There are several unconventional approaches to 
treatment; including homeopathic treatments and “home remedies” (see Niven, 2005). 
However, as these are not endorsed or recommended by most vets in South Africa, costs 
incurred administering them are considered negligible. The model does, however, account 
for the administration of antibiotics and anti-inflammatories (to reduce the oedema), as 
well as any additional labour required to attend to a sick horse. These make up the 
treatment costs. 
Diagnostic costs are composed of veterinarian fees, the cost of samples and post 
mortems for the horse-owner’s account. Once a horse owner has seen the symptoms of 
AHS, it is unlikely that he or she will call out a vet to diagnose subsequent cases, so this 
component of the costs will be likely to be small, or diminishing. Furthermore, if a horse-
owner wishes to have blood samples taken, or a post mortem conducted, the expenses 
incurred can be claimed back from the state, should the owner go through the official 
channels.  
Control measures accounted for by the model include the administration of the AHS 
vaccine, either by a veterinarian or other party; the application of insecticide to stables, 
vehicles and horses; the instalment of fans in stables; the erection of shade cloth on the 
premises; and the cost of quarantining a horse at the various quarantine facilities available 
for South African horses.   
Details of the model specification are provided below: 
 
(a) Production Losses 
P = MT + ABSB                 (3.1) 
 
Where MT = mortality 
ABSB = abortions and still births 
 
Further:  MT = ∑i (vi + 12.kci.yri + rc)                                  (3.1.1) 
 
Where vi = estimated value of the horse lost 
kci = estimated average cost of keeping a horse/month 
yri = age of horse lost 
rc = cost incurred to have carcass removed 
i = each horse lost to AHS 
 
ABSB = ∑jfvj                                       (3.1.2) 
 
Where: fvj = estimated value of the foal at birth 
j = each case of abortion or stillbirth due to infection 
 
(b) Treatment Costs 5 
 
T =aAI . cAI+ aAB.cAB + ot.pot                          (3.2) 
 
Where aAI = number of horses treated with anti-inflammatories.  
cAI = cost of the average course of treatment with anti-inflammatories 
aAB = number of horse treated with antibiotocs  
cAB = cost of the average course of treatment with antibiotics 
ot = number of extra labour hours paid for 
pot = price of extra labour hours  
 
(c) Diagnostic Costs 
D = VET.pVET + samples. (price of test) + pm.ppm         (3.3) 
   
Where VET = cost of veterinarian’s labour 
PVET =cost of vet’s labour for diagnosis 
samples = number of samples taken 
price of test = price of testing each sample 
pm =number of post mortems performed at owner’s expense  
ppm = cost of a post mortem 
 
(d) Cost of Control Measures 
M = TI + VC + QC + sc.psc + f.pf            (3.4) 
 
Where TI = cost of spraying with insecticide 
VC = cost of vaccination 
QC = cost of quarantine 
sc = meters of shade cloth erected on premises 
psc = average price of shade cloth per meter 
f = number of fans installed on premises 
pf = average price per fan 
 
And further:  
TI = (nsIT . fsIT . price per stable + naIT . faIT . price per animal + nvIT . fvIT . price per 
vehicle).duration of outbreak (months)                                                                     (3.4.1) 
 
Where: nsIT = number of stables sprayed 
fsIT = frequency with which stables sprayed per month 
na IT = number of animals sprayed 
faIT = frequency with which stables sprayed per month 
nvIT = number of vehicles sprayed 
fvIT = frequency with which stables sprayed per month 
 
And: VC = naVC . priceVC (PV . ac + Psa).2                                                                 (3.4.2) 
  
Where: naVC = number of horses vaccinated over this period 
priceVC = price of vaccine 
PV = proportion of animals whose vaccination was administered by a veterinarian 
ac = administration cost 6 
 
Psa = proportion of animals vaccinated by animal owner or caretaker 
 
And: QC = naQK.pQK + naQM.pQM + naQN.pQN                    (3.4.3) 
 
Where: naQk = number of animals quarantined at Kenilworth 
pQK = price of 40 days of quarantine at Kenilworth 
naQM = number of horses quarantined in Mauritius  
pQM = price of 40 days of quarantine in Mauritius 
naQN = number of animals quarantined at Newburg 
pQN = price of 40 days quarantine at Newburg 
 
4.  LIMITATIONS AND ASSUMPTIONS OF THE MODEL 
 
It must be acknowledged that the model is significantly limited in several ways.  
It is difficult to objectively assign a monetary value to a horse. Firstly, it may be argued 
that it is unethical to assign a value to certain things that do not have market values 
(Ngategize et al., 1986: 192). The market value of a horse may not reflect its true value to 
the  owner,  which  is  likely  to  depend  on  unobservable  factors  such  as  the  horse’s 
potential, its temperament, its genetic suitability for breeding, the level of sentimentality 
that the owner places on it or other such intangible attributes. Aside from this, the vast 
discrepancy in the values of horses based on these attributes makes it very difficult to 
objectively  assign  a  value  to  any  given  horse,  as  the  researcher  always  requires  the 
guidance  of  the  owner  in  discerning  the  horse’s  value.  It  may  be  possible  to 
mathematically model the value of a horse based on more objective data which could be 
provided by the owner, displacing the owner’s subjective power in providing a value, 
however, this is beyond the scope of this study. As a result, owners were asked to provide 
an  estimate  of  the  value  of  each  horse  they  lost,  and  production  losses  had  to  be 
calculated separately for each horse. The mathematical modelling of horse values would 
reduce  the  repetition  required  in  calculating  production  losses,  and  would  make  the 
model less subjective and hence more credible.  
Similarly, owners were required to provide the potential value of each foal lost to 
stillbirth  or  abortion.  This  estimation  is  also  subjective,  and  is  further  based  on  the 
breeders’ perception of the foals’ lineage.   
The cost of removing a carcass from the breeder’s premises was established using the 
average of costs reported by each breeder. This limits the accuracy of the model, as these 
costs may also vary greatly between premises and removal methods 
The model assumes that the cost of keeping a horse is the same for any horse on any 
premises, where this cost can vary significantly according to, for example, how much 
training, food and veterinary attention it requires; and the availability of suitable feed in 
the area. Where brood mares may not require training, horses being groomed for sale may 
require expensive training; where young horses may live out, horses in training may be 
stabled, and so forth. The figure used in this study was based on an average of the 
estimates of a monthly cost of keep provided by each individual breeder. 
The model does not account for veterinarian travel costs, which, as most studs are 
based outside of urban areas, may form a significant part of the routine cost of AHS to a 
breeder.  7 
 
 The model assumes that the cost of vaccine is R70 where some outlets may charge 
more than this. This figure is based on an average of several accounts of the amount paid 
for vaccine. The cost of spraying a horse, vehicle or stable were also estimated at R5 each, 
based on the most commonly purchased insecticide at a local veterinarian. The frequency 
of spraying was assumed to be once every two days over the period of analysis. 
Similarly, the cost of antibiotics and anti-inflammatories were based on the price of 
administering them to the average full-grown horse for five days, obtained from one local 
veterinarian. Dosages, duration of treatment and outlet prices may vary for each case. 
Lastly, limiting the treatments considered to antibiotics and anti-inflammatories may 
be oversimplifying this component of the total impact. Further research indicated that 
some  veterinarians  may  recommend  much  more  extensive  treatments  such  as  the 
administration  of  a  bronchodilator;  a  diuretic;  and  possibly  a  course  of  vitamin  C. 
Estimates obtained from one veterinary clinic, and based on a five day administration of 
these treatments could cost owners around R1 700 per grown horse. 
5.  APPLICATION OF THE MODEL TO THE EASTERN CAPE 
 
Data for each variable specified in the model was collected from four stud farms in the 
province, detailing their costs and losses relating to AHS between October 2007 and May 
2008, as these are the dates between which the AHS virus was present in the province 
(AHS  Trust,  2010).  The  data  were  entered  into  the  model,  which  revealed  a  total 
economic impact of R2 513 979 for four farms over this period.  
It is notable that 83.9% of the total impact can be attributed to the losses incurred due 
to the mortality (MT) as specified by equation (3.1.1). More specifically, the actual values 
of the horses lost, as estimated by their owners and represented by vi in equation (3.1.1), 
contributed 28% of the total impact. Thus the issue of allowing breeders to subjectively 
assign values to horses becomes significantly problematic and the need for an objective 
method of valuation is emphasised. However, it must also be acknowledged that sport 
horses  do  fetch  high  prices  in  reality,  and  thus  this  high  figure  is  not  completely 
unjustifiable. The average reported price of horses lost was in the region of R40 000. 
The research process revealed that the questionnaire was effective in acquiring the 
relevant data and was seldom misinterpreted. Responses from the four breeders indicated 
that the research questions were reasonable and relevant, thus indirectly reaffirming the 
completeness of the model for its intended purpose. 
 
6.  PROSPECTS FOR EXTENDING THE MODEL 
The model is designed specifically for the equine breeding industry in South Africa. An 
extensive study of the economic impact of AHS in South Africa would have to consider 
costs and losses incurred much more broadly. For example, the disease may significantly 
impact the horse racing industry; equine tourism industries such as game rides, trail rides 
and beach rides; the revenue of sport organising bodies for all equine disciplines such as 
endurance, saddler competitions, tripling, etc. Leisure riding is also adversely affected by 
AHS. Here, the valuation of the impact is a much more tricky business, as the value of 
goods such as leisure; emotional attachment and social status is particularly difficult to 
establish. AHS also impacts heavily on  the informal sector and in rural  areas, where 
horses and ponies are used, for example, as a mode of transport, as working horses and 
stock horses; and owners are not able to afford vaccines. Here, horses form a large part 8 
 
of people’s livelihoods, and their death can have devastating effects on people’s income 
and welfare as a result. 
There is a need for improved data collection methods, and perhaps it would even be 
prudent to build a culture of data recording amongst stakeholders. Effective models rely 
on credible data sources, and at present, some of the data is produced by estimation. The 
African Horse Sickness Trust has put together an online database that acts as an early 
warning system to horse owners, but this can only reach certain sectors of the equine 
economy, as many stakeholders do not have access to the internet, or do not report cases 
to the Trust.  
7.  LOSS-EXPENDITURE FRONTIER 
McInerney et al. (1992: 142-143) point out that economic evaluations which report the 
total costs of a disease fail to recognise that, for technical reasons, most diseases cannot 
be completely eradicated. “It is not the total economic cost of the disease that is useful 
information, therefore, but rather the avoidable costs.” (McInerney et al., 1992: 143). The 
avoidable costs are thus the ones that are able to guide decisions based on economic 
considerations.    
A loss-expenditure frontier (LEF) can be used to identify endemic disease control 
strategies that minimise total costs by finding an optimal balance between output loss and 
control expenditure (Stott and Gunn, 2008: 180). The LEF provides a method of making 
decisions  based  on  the  optimization  of  loss  and  expenditures  so  that  the  economic 
impact of a disease can be minimized (Houe, 2003: 138; McInerney et al., 1992: 141). 
Control expenditures are plotted  against production losses, and when the former are 
increased, the latter will decrease. It is only justifiable to increase control expenditures as 





Figure 1: The loss-expenditure frontier (McInerney et al., 1992: 141). 
 
In Figure 1, if nothing was spent on control, output losses would amount to L. The line 
LL’ shows the minimum level of output loss that can technically be attained at each level 9 
 
of expenditure, and therefore represents the efficient set of control options and their 
corresponding expenditures and output losses (McInerney et al., 1992: 143). Points below 
the line are unattainable due to a lack of knowledge. The curve’s diminishing downward 
slope indicates the postulation that increases in expenditures become progressively less 
effective in reducing losses (McInerney et al., 1992: 142). The asymptotic nature of the 
curve on the y-axis indicates that it is not possible to completely remove output losses. 
For diseases that can be eradicated or avoided completely, the graph would intersect the 
x-axis. However for most diseases, the technical point of efficiency is represented by 
point A on the graph. The objective here is to find the economic optimum, the point on 
the curve where economic cost, L + E, is minimized. This can be found at point M, 
closest to the origin and corresponding with expenditures of   and output loss of  . 
At this point, the marginal unit of expenditure on control is just covered by the gain in 
reduced output losses, represented by ( ), and total costs equal  ). At this 
point, the avoidable costs of the disease have been minimized to zero.  
To illustrate the application of this model, consider the example of a study conducted 
on Mastitis control strategies in the Netherlands (McInerney et al., 1992). Figure 2 shows 
how the LEF is derived by plotting combinations of output loss and control expenditure.  
 
Figure 2: Output losses and control expenditures for different farms in a Mastitis Survey. (Numbers refer to the 18 
different control procedures) (McInerney et al., 1992: 146). 
 
Each point in the quadrant represents the combination of output losses and control 
expenditures associated with different control strategies for Mastitis in the Netherlands 
(McInerney et al., 1992: 146). The LEF is revealed as the lower boundary of each of these 
observations, and the point of optimum control expenditure can be identified as that 
which is tangent to a line with a slope of -1, closest to the origin. 
The current study assessed the effectiveness of the LEF as a tool for advising on 
efficient  control  strategies  in  the  case  of  AHS.  Both  output  losses  and  control 
expenditures are already calculated in the model, where the former is simply equal to P 
(production losses) and the latter is equal to M (cost of control measures). In the case of 
AHS, it was hypothesised that the LEF could give an indication of the optimal level of 
control  expenditure  that  yields  an  efficient  level  of  output  loss,  providing  useful 
information for stakeholders in the industry.  10 
 
Plotting  the  combinations  of  output  losses  and  control  expenditures  for  the  four 
farms  surveyed  in  this  study  did  not  reveal  a  pattern  that  might  indicate  an  LEF. 
However, it is not unreasonable to predict that a significantly larger data set would reveal 
one. It would also be necessary to consider that, without the loss of horses on a farm, the 
researcher cannot be certain that infected midges were present on the farm (unless there 
were  horses  on  the  farm  that  were  infected  but  survived),  and  thus  the  absence  of 
mortality may not reflect the efficiency of the level of control present on that farm. Thus 
it might be necessary to remove observations where output losses were not incurred and 
where  there  was  no  evidence  that  AHS  was  present  on  the  farm.  Moreover,  it  was 
concluded that sport-horse values are much more disparate than other livestock values, 
due  to  their  being  based  on  much  more  subjective  and  diverse  factors  such  as 
conformation, temperament, sport performance (or potential to perform), and so on. In 
the case of AHS, as the value of horses lost on each farm contributes significantly to 
output losses, and given the fact that there can be such vast disparity between the values 
of any two sport horses; the LEF is in fact not a useful indicator of the optimal level of 
control expenditure for sport-horse breeders. Unlike the case of diseases affecting, for 
example, cattle and sheep, where the disease reduces outputs such as milk, wool or meat, 
horses  infected  with  AHS  either  recover  or  die.  This  means  that  output  losses  are 
determined solely by mortality, whereas the LEF model was constructed to reflect a wider 
range of losses that are valued by the market rather than the farmers themselves. 
 Drawing  from  the  idea  of  the  LEF,  however,  it  may  be  useful  to  construct  an 
instrument that plots the number of horses lost against the level of control expenditure 
on each farm, allowing breeders to evaluate and consider the potential losses risked at 
each level of expenditure.  
 
8.  FURTHER COMPLEXITIES 
 
There  are  several  dynamics  related  to  the  control  of  AHS  which  complicate  the 
effectiveness  of  any  control  strategy,  and  thus  limit  the  ability  of  an  extensive 
deterministic  model  and  an  LEF-type  approach  to  inform  action.  Some of these  are 
outlined here. 
Equids in rural areas (especially donkeys, which act as a reserve of AHS, but are not 
affected  by  the  disease)  are  seldom  vaccinated,  as  owners  either  cannot  afford  to 
vaccinate; do not have access to vaccination or the refrigeration required to keep it; or are 
not aware that they should vaccinate. It is thus important that the price of vaccine be 
significantly reduced in order to lessen the occurrence of the disease in these areas, and 
hence its spread to other areas too. This could be achieved by the production of the 
vaccine by more companies, bringing the price down, encouraging more people to buy 
the vaccine, and also creating the opportunity for the development of vaccination clinics 
which could reach a much wider population.  
Zebras also act as a reservoir of the disease, but because they show no signs of being 
infected,  they  are  not  vaccinated.  This  undermines  the  efforts  of  other  equine 
stakeholders to limit the spread of the disease through vaccination. This is a particularly 
problematic issue, as the increase in the development of private game farms around the 
country results in increased potential for exposure to the disease. The vaccination of 
zebras is also likely to be a difficult task, with little or no benefit to the game farms, and is 
therefore something that requires further research. 11 
 
Even if the whole equid population in South Africa was vaccinated regularly, the 
vaccine does not provide complete protection against AHS, and so losses may still occur 
(Niven, 2005). This highlights the significance of the need for further scientific research 
in the area. It is proposed that a comprehensive study on the economic impacts of AHS 
in South Africa conducted with the aid of an extensive version of the model developed in 
this study would motivate stakeholders and funders to encourage such research. 
 
9.  CONCLUSION 
 
This study set out to construct an appropriate deterministic model for the calculation of 
the economic impact of AHS to the equine breeding industry in South Africa and to run 
the model using data from a small number of stud farms in the Eastern Cape over the 
2007/2008  outbreak  period.  A  satisfactory  model  was  developed,  though  some 
limitations of its scope were identified. Of particular importance is the limitation created 
by the subjective valuation of horses lost, especially given that output losses constituted 
83.9% of the total economic impact of AHS to the four farms surveyed. The modelling 
of equine values was thus identified as a key area requiring more research. The model 
serves as a good starting point for the development of a more extensive model, able to 
calculate the impact of the disease to other equine sectors. It was noted that the inclusion 
of losses incurred in rural and informal areas is imperative, as this loss is particularly 
devastating to horse-owners and this area is frequently overlooked.  
The study then illustrated the usefulness of the application of a Loss-Expenditure 
Frontier to the case of AHS in South Africa, as it showed potential as a tool in identifying 
efficient  control  strategies  for  stakeholders  and  the  realistic  potential  for  better 
preventative measures to reduce losses. However, it was concluded that the LEF was not 
appropriate for the case of AHS, due to the extent of disparities in the prices of horses. It 
was suggested that a similar model, plotting control expenditures against the number of 
horses lost in each case, would be more useful. 
It is proposed that an extended model based on the one developed here, which tackles 
the problem of equine valuation and includes a much larger range of sectors, has the 
potential to encourage and enable increased research into improved prevention, control 
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